A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

Health Canada has approved Novartis Canada’s Fabhalta (iptacopan capsules) as the first oral monotherapy to treat adults with ...

Fintel reports that on February 13, 2025, UBS downgraded their outlook for Novartis AG - Depositary Receipt () (NYSE:NVS) ...

Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

Since 2021, there’s been an increase in representation of people from underrepresented and underserved communities in Super ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

We recently published a list of 10 Best Mid-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...

Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Roche Holding AG’s US unit removed diversity and inclusion targets from its website, the latest in a series of publicly ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...